Urticaria and autoimmunity: Where are we now?

Current Allergy and Asthma Reports

Volumn 13, Issue 5, 2013, Pages 555-562

  Stitt, Jenny M ^a   Dreskin, Stephen C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Autoimmunity; Autologous serum skin test; Basophil histamine release; Hives; Thyroiditis; Urticaria; Witebsky's postulates

Indexed keywords

ANTIHISTAMINIC AGENT; AUTOANTIBODY; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOTHYROXINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; OMALIZUMAB; PLACEBO; RITUXIMAB; SALAZOSULFAPYRIDINE; THYROID ANTIBODY;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; AUTOLOGOUS SERUM SKIN TEST; BASOPHIL; CHRONIC URTICARIA; DISEASE ASSOCIATION; GENETIC ASSOCIATION; HISTAMINE RELEASE; HUMAN; HYPOTHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PLASMAPHERESIS; PROGNOSIS; PTPN22 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN TEST; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BASOPHILS; HISTOCOMPATIBILITY ANTIGENS; HUMANS; SKIN TESTS; URTICARIA;

EID: 84885189013     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-013-0366-8     Document Type: Article

References (63)

1. Sánchez-Borges M, Asero R, Ansotegui I, et al. Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective. WAO J. 2012;5:125-47.
2. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today. 1993;14(9):426-30.
3. Grattan CEH, Francis DM. Autoimmune Urticaria. In: James WD, Cockerell CJ, Dzubow LM, Paller AS, Yancey KB, editors. Advances in Dermatology. St Louis: Mosby Inc; 2000. p. 311-400.
4. Pastore S, Berti I, Longo G. Autoimmune chronic urticaria: transferability of autologous serum skin test. Eur J Pediatr. 2013;172(4):569.
5. • Bagnasco M, Minciullo PL, Saraceno GS, Gangemi S, Benvenga S. Urticaria and thyroid autoimmunity. Thyroid. 2011;21(4):401-10. This is a comprehensive review of studies exploring the relationship between urticaria and thyroid autoimmunity.
6. Grattan CE, Boon AP, Eady RA, Winkelmann RK. The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions. Int Arch Allergy Appl Immunol. 1990;93(2-3):198-204.
7. O'Donnell BF, O'Neill CM, Francis DM, et al. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol. 1999;140(5):853-8.
8. Grattan CE, O'Donnell BF, Francis DM, et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol. 2000;143(2):365-72.
9. Vena GA, Cassano N, Colombo D, Peruzzi E, Pigatto P. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol. 2006;55(4):705-9.
10. • Trojan TD, Khan DA. Calcineurin inhibitors in chronic urticaria. Curr Opin Allergy Clin Immunol. 2012;12(4):412-20. This is a comprehensive meta-analysis of the use of cyclosporine in the treatment of chronic urticaria.
11. •• Confino-Cohen R, Chodick G, Shalev V, et al. Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol. 2012;129(5):1307-13. This is a retrospective review of the association between chronic urticaria and autoimmune disease over time in a large HMO database.
12. Kumar K, Kole AK, Karmakar PS, Ghosh A. The spectrum of thyroid disorders in systemic lupus erythematosus. Rheumatol Int. 2012;32(1):73-8.
13. Mozena JD, Tiñana A, Negri J, Steinke JW, Borish L. Lack of a role for cross-reacting anti-thyroid antibodies in chronic idiopathic urticaria. J Invest Dermatol. 2010;130(7):1860-5.
14. Kirkpatrick CH. A mechanism for urticaria/angioedema in patients with thyroid disease. J Allergy Clin Immunol. 2012;130(4):988-90.
15. Rumbyrt JS, Katz JL, Schocket AL. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol. 1995;96:901-5.
16. Sheikh J, Saini SS, Kulczycki Jr A, Dreskin SC. A survey of allergists regarding the association of thyroid autoimmunity with chronic urticaria. J Allergy Clin Immunol. 2009;123(5):1173-5.
17. Kiyici S, Gul OO, Baskan EB, et al. Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity. Clin Exp Dermatol. 2010;35(6):603-7.
18. Magen E, Mishal J. The effect of L-thyroxine treatment on chronic idiopathic urticaria and autoimmune thyroiditis. Int J Dermatol. 2012;1:94-7.
19. •• Konstantinou GN, Asero R, Ferrer M, et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy. 2013;68(1):27-36. A review of all the evidence for autoimmune urticaria with proposed diagnostic criteria by the ECAAI.
20. Cho CB, Stutes SA, Altrich ML, et al. Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders. Ann Allergy Asthma Immunol. 2013;110(1):29-33.
21. Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol. 2002;109(4):694-700.
22. Oztas P, Onder M, Gonen S, Oztas MO, Soylemezoglu O. Is there any relationship between human leucocyte antigen class II and chronic urticaria? (chronic urticaria and HLA class II). Yonsei Med J. 2004;45(3):392-5.
23. Aydogan K, Karadogan SK, Akdag I, Tunali S. HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria. Clin Exp Dermatol. 2006;31(3):424-9.
24. Coban M, Erdem T, Ozdemir S, et al. HLA class I and class II genotyping in patients with chronic urticaria. Int Arch Allergy Immunol. 2008;147(2):135-9.
25. Calamita Z, Pelá Calamita AB. Chronic spontaneous urticaria: epidemiological characteristics focusing on the histocompatibility profile and presence of antibodies. Inflamm Allergy Drug Targets. 2013;12(1):8-11.
26. Brzoza Z, Grzeszczak W, Trautsolt W, Moczulski D. Protein tyrosine phosphatase-22 (PTPN-22) polymorphism in the pathogenesis of chronic urticaria. Allergy. 2011;66(10):1392-3.
27. Brzoza Z, Grzeszczak W, Rogala B, Trautsolt W, Moczulski D. PTPN22 polymorphism presumably plays a role in the genetic background of chronic spontaneous autoreactive urticaria. Dermatology. 2012;224(4):340-5 [abstract].
28. Grattan CE, O'Donnell BF, Francis DM, et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol. 2000;143:365.
29. Kessel A, Toubi E. Cyclosporine-A in severe chronic urticaria: the option for long-term therapy. Allergy. 2010;65(11):1478-82.
30. Shahar E, Bergman R, Guttman-Yassky E, Pollack S. Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids. Int J Dermatol. 2006;45(10):1224-7.
31. Zimmerman AB, Berger EM, Elmariah SB, Soter NA. The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients. J Am Acad Dermatol. 2012;66:767.
32. Morgan M, Khan D. Therapeutic alternative for chronic urticaria: an evidence-based review, part 1. Ann Allergy Asthma Immunol. 2008;100(5):403-11.
33. Morgan M, Khan D. Therapeutic alternative for chronic urticaria: an evidence-based review, part 2. Ann Allergy Asthma Immunol. 2008;100(6):517-26.
34. Asero R, Tedeschi A. Usefulness of a Short Course of Oral Prednisone in Antihistamine-Resistant Chronic Urticaria: A Retrospective Analysis. J Investig Allergol Clin Immunol. 2010;20(5):386-90.
35. Grattan CE, Francis DM, Slater NG, Barlow RJ, Greaves MW. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet. 1992;339(8801):1078-80.
36. O'Donnell BF, Barr RM, Black AK, et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol. 1998;138(1):101-6.
37. Chakravarty SD, Yee AF, Paget SA. Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies. J Allergy Clin Immunol. 2011;128(6):1354-5.
38. Arkwright PD. Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria. J Allergy Clin Immunol. 2009;123(2):510-1.
39. Malmros H. Autoserumtest (A.S.T.). Nordisk Med. 1946;29:150-1 [abstract].
40. Grattan CE, Wallington TB, Warin RP, Kennedy CT, Bradfield JW. A serological mediator in chronic idiopathic urticaria-a clinical, immunological and histological evaluation. Br J Dermatol. 1986;114(5):583-90.
41. Sabroe RA, Grattan CE, Francis DM, et al. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol. 1999;140(3):446-52.
42. Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol. 2006;117(5):1113-7.
43. Kocatürk E, Kavala M, Kural E, SarIgul S, ZIndancI I. Autologous serum skin test vs autologous plasma skin test in patients with chronic urticaria: evaluation of reproducibility, sensitivity and specificity and relationship with disease activity, quality of life and anti-thyroid antibodies. Eur J Dermatol. 2011;21(3):339-43.
44. Konstantinou GN, Asero R, Maurer M, et al. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64(9):1256-68.
45. Guttman-Yassky E, Bergman R, Maor C, et al. The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individuals. J Eur Acad Dermatol Venereol. 2007;21(1):35-9.
46. Fusari A, Colangelo C, Bonifazi F, Antonicelli L. The autologous serum skin test in the follow-up of patients with chronic urticaria. Allergy. 2005;60(2):256-8.
47. Bélot V, Desbois I, Martin L, et al. Assessment of the usefulness of autologous serum skin testing in chronic urticaria: a retrospective single-centre study of 74 patients. Ann Dermatol Venereol. 2010;137(6-7):444-50 [abstract].
48. Toubi E, Blant A, Kessel A, Golan TD. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy. 1997;52(3):312-6.
49. Hollander SM, Joo SS, Wedner HJ. Factors that predict the success of cyclosporine treatment for chronic urticaria. Ann Allergy Asthma Immunol. 2011;107(6):523-8.
50. Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008;122(3):569-73.
51. Saini S, Rosen KE, Hsieh HJ, et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol. 2011;128(3):567-73.
52. • Maurer M, Rosén K, Hsieh HJ, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013;368(10):924-35. Double blind randomized placebo-contolled trial of omalizumab in chronic urticaria.
53. Hide M, Francis DM, Grattan CE, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328(22):1599-604.
54. Fiebiger E, Hammerschmid F, Stingl G, Maurer D. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest. 1998;101(1):243-51.
55. Soundararajan S, Kikuchi Y, Joseph K, Kaplan AP. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol. 2005;115(4):815-21.
56. Yasnowsky KM, Dreskin SC, Efaw B, et al. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol. 2006;117(6):1430-4.
57. Sabroe RA, Fiebiger E, Francis DM, et al. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol. 2002;110(3):492-9.
58. Biagtan MJ, Viswanathan RK, Evans MD, Mathur SK. Clinical utility of the Chronic Urticaria Index. J Allergy Clin Immunol. 2011;127(6):1626-7.
59. Viswanathan RK, Biagtan MJ, Mathur SK. The role of autoimmune testing in chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2012;108(5):337-41.
60. Najib U, Bajwa ZH, Ostro MG, Sheikh J. A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2009;103(6):496-501.
61. Eckman JA, Hamilton RG, Saini SS. Independent evaluation of a commercial test or "autoimmune" urticaria in normal and chronic urticaria subjects. J Invest Dermatol. 2009;129(6):1584-6.
62. Kozel MM, Bossuyt PM, Mekkes JR, Bos JD. Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: A systematic review. J Am Acad Dermatol. 2003;48(3):409-16.
63. Tarbox JA, Gutta RC, Radojicic C, Lang DM. Utility of routine laboratory testing in management of chronic urticaria/angioedema. Ann Allergy Asthma Immunol. 2011;107(3):239-43.